Skip to main content
Equibles

Aberdeen Group plc

Position in ADPT — Adaptive Biotechnologies Corp

CIK 1716774 EDINBURGH, X0
Back to ADPT Full portfolio

Position in ADPT

as of Jun 30, 2026 · filed Jul 31, 2026
Position Value
$4,928,126
+$4,928,126 QoQ
Shares Held
229,750
-14.2% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#5
of 70 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADPT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Aberdeen Group plc holds $1,035,545,424 across 24 Diagnostics & Research names. ADPT ranks #22 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DHR
Danaher Corp /De/
 1,339,185 $255,087,958
2 TMO
Thermo Fisher Scientific Inc.
 461,039 $231,146,511
3 ICLR
Icon PLC
 394,362 $68,504,622
4 WAT
Waters Corp /De/
 138,104 $51,794,522
5 PSNL
Personalis, Inc.
 3,747,290 $50,213,686
6 IDXX
Idexx Laboratories Inc /De
 91,286 $48,056,601
7 IQV
Iqvia Holdings Inc.
 238,810 $46,142,867
8 A
Agilent Technologies, Inc.
 288,030 $38,259,024

All Filings in ADPT

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,928,126 918,998
2026-03-31 — 1,070,627
2025-12-31 — 1,046,510
2025-09-30 — 993,967
2025-06-30 — 1,031,059
2025-03-31 — 1,197,622
2024-12-31 — 1,004,059
2024-09-30 — 1,029,447
2024-06-30 — 1,029,447
2024-03-31 — 1,029,447
2023-12-31 — 933,794